Status:
COMPLETED
COVID-19 Vaccine Text Outreach
Lead Sponsor:
University of Pennsylvania
Conditions:
Covid19
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach prog...
Detailed Description
This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims...
Eligibility Criteria
Inclusion
- patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)
Exclusion
- Patients who have completed any dose of the vaccine at Penn Medicine, are currently scheduled to receive the vaccine, have externally documented vaccination records, or have previously received text-message based vaccine outreach.
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2021
Estimated Enrollment :
19554 Patients enrolled
Trial Details
Trial ID
NCT04834726
Start Date
April 29 2021
End Date
July 6 2021
Last Update
March 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104